Prospect Capital Corporation vs Stryker Corporation — how do they compare? Prospect Capital Corporation trades at $2.15 (market cap $1.08B), while Stryker Corporation trades at $309.5 (market cap $120.60B). The key difference: Stryker Corporation is far larger — about 111.7× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays the higher dividend (23.26%). Which is the better fit depends on your goals.
| PSEC | SYK | |
|---|---|---|
Market Cap | $1.08B | $120.60B |
Sector | Financials | Technology |
52-Week High | $3.47 | $403.53 |
52-Week Low | $2.15 | $282.58 |
Dividend Yield | 23.26% | 1.12% |
Enterprise Value | — | $132.36B |
Trailing returns across standard periods
Latest headlines on both assets
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Read more on PSEC →Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →